News

  • The Senior Citizens League Weekly Update For Week Ending November 22 2019

    COLA cuts: Use the "chained" Consumer Price Index (CPI) to calculate annual cost-of-living adjustments (COLAs). Supporters say that the difference would be small, reducing the COLA about .3 tenths of a percentage point per year. But TSCL estimates this "small" change would cost retirees, with average benefits of ,170 in 2011, some ,223 over a 25-year retirement. .Most Americans contribute 6.2 percent of every paycheck to Social Security, but due to the payroll tax cap, people earning more than 8,400 contribute nothing over that amount. Eliminating the payroll tax cap would extend the solvency of the program responsibly, without cutting benefits for seniors. Do you agree? .The result of that analysis is precisely why we've opposed the President's order. To make matters worse, there is no plan on how to replace the money the Social Security and Medicare systems will lose if the temporary tax deferral becomes permanent. … Continued

  • Center For Disease Control Has New Guidance For Those Fully Vaccinated

    I turn 61 this year and I'm still employed. I've read about waiting until my full retirement age before starting Social Security benefits. Is that 66? Do I enroll in Medicare at the same time I start Social Security? .The Department of Justice (DOJ) has filed charges against more than half a dozen people accused of pushing silver products and other fake treatments for Covid-1The Federal Trade Commission (FTC) has gotten the marketer of a Vitamin C supplement to stop claiming it can treat the virus. And the FTC and Food and Drug Administration have been sending dozens of joint warning letters to companies for touting unapproved treatments or preventatives. .Throughout the hearing, the "big dog" in the room – as one witness referred to it – was the Sustainable Growth Rate (SGR). Each of the witnesses urged the Subcommittee Members to replace the current Medicare physician payment formula with a new model, saying that there's simply too much uncertainty surrounding the SGR. Though most seemed to agree, the price tag of repealing the SGR is daunting and the process of re-writing a billing system with 8,000 different codes will certainly take time. … Continued

TSCL Endorses New COLA Legislation . Paula chose to take the employer-provided Medicare supplement, dental and vision coverage at 6 per month, but "opted out" of the expensive Part D. Instead we found more reasonably priced drug coverage at .90 per month, and covering the prescriptions she currently took with no deductible, using the Medicare Drug Plan Finder at www.medicare.gov. .He announced that he would meet with the drug companies to discuss his plan, but top company executives subsequently refused to meet with him. The drug companies did develop their own proposal but it was rejected by the President. .For more information on town hall meetings near you during the August recess, click HERE. For more sample town hall questions, read this month's Legislative Update HERE. .The plan contained a list of 50 military treatment facilities that would see changes in some way over the next several years in the services they offer. Of those, 37 would stop seeing military family members and retirees altogether. At least 12 states would have more than one treatment facility changed with regard to its mission. .By Jessie Gibbons, Legislative Director .Our seniors worked hard all their lives and paid into the system – they've earned the right to true peace of mind. But the COLA formula in place right now just isn't providing that peace of mind. It's imbalanced and creating uncertainly for millions of Americans. .TSCL is happy to hear that. However, we also know that the big drug companies are spending millions of dollars lobbying heavily against legislation in Congress that would lower drug prices. So, we remain skeptical of his intentions until we actually see a proposal or proposals to do what he claims the drug companies want to do. .Because COVID-19 has never been seen in humans before, there are currently no vaccines to prevent COVID-19 approved by the U.S. Food and Drug Administration (FDA). The FDA recently approved the first treatment for COVID-19, the antiviral drug remdesivir.